No, repeating injections in the same spot too frequently causes lipohypertrophy or lipoatrophy, which slows medication absorption and reduces weight loss effectiveness
Louis, MO), editor-in-chief of Circulation: Heart Failure , said that clearly, this idea that adipose tissue is bad and less adipose tissue is good is becoming a very strong theme. Its not surprising that patients with the most-severe obesity derived the greatest benefits in terms of quality of life in SUMMIT, she added, but said its reassuring that there isnt some level of obesity thats so great that you dont benefit. Obesity Severity in SUMMIT In the United States, about two-thirds of patients with HFpEF have the obesity phenotype, and the pathophysiological abnormalities present in this setting all correlate to the amount of excess body weight, and body fat in particular, Borlaug said
This drug is not yet FDA approved
Lab work is included where needed, too: the initial $45 covers a metabolic blood test if your provider orders one, done at Quest or through a $75 at-home kit (free if Quest is not in your state)
Documentation and handling reference Tirzepatide: Documentation, Handling and Quality Record for This SKU The section above covers what Tirzepatide is and what the published literature has looked at